Search results
Our Products. Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options. With a presence in approximately 100 countries, we are proud to have reached millions of people with our products.
- What We Do
Amgen collects, reviews, and evaluates adverse events,...
- Responsibility
Our ESG Framework . Amgen’s ESG framework is built on four...
- What We Do
People also ask
How many drugs does Amgen sell?
What products are marketed by Amgen?
Does Amgen treat serious illnesses?
Does Amgen use genetics?
- Overview
- Latest news
- Drugs Associated with Amgen Inc.
•Amgen Provides Regulatory Update on Status of Lumakras (sotorasib)
26 December 2023
•FDA Grants Priority Review to Amgen's Tarlatamab Application for Advanced Small Cell Lung Cancer
13 December 2023
•FDA Approves Wezlana (ustekinumab-auub), an Interchangeable Biosimilar to Stelara
31 October 2023
Amgen Inc. manufactures, markets and/or distributes more than 35 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
Amgen's approved drugs or therapeutic biologicals include: Aimovig (erenumab-aooe) for migraine headaches (FDA approved May 2018) Amjevita ; Aranesp (darbepoetin alfa) for anemia (FDA approval in September 2001) Blincyto (blinatumomab for the treatment of acute lymphoblastic leukemia) Corlanor
Jun 15, 2023 · Amgen produces drugs to treat several conditions and markets them worldwide. Learn its revenue-earning structure and how it makes money.
Feb 20, 2024 · Amgen is among the larger biotech and pharma companies by market capitalization worldwide. Biopharmaceuticals manufactured by Amgen are also among the leading biotech drugs worldwide.
Take a deeper dive into the latest data in the ninth edition of Amgen’s Biosimilar Trends Report, which provides a detailed look at the current state of the U.S. marketplace across oncology, inflammation and nephrology.
A robust pipeline leveraging state-of-the-art science and molecular engineering focused on the pursuit of transformative medicines with large effects in serious diseases.
